Nplate and Cataract - a phase IV clinical study of FDA data
Summary:
Cataract is reported as a side effect among people who take Nplate (romiplostim), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Simvastatin, and have Idiopathic thrombocytopenic purpura.
The phase IV clinical study analyzes which people have Cataract when taking Nplate. It is created by eHealthMe based on reports of 17,818 people who have side effects when taking Nplate from the FDA, and is updated regularly.
What is Nplate?
Nplate has active ingredients of romiplostim. It is often used in idiopathic thrombocytopenic purpura (itp). eHealthMe is studying from 17,850 Nplate users. Check the latest studies of Nplate.
What is Cataract?
Cataract (clouding of the lens inside the eye) is found to be associated with 1,892 drugs and 2,133 conditions by eHealthMe. Check the latest studies of Cataract.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
17,818 people reported to have side effects when taking Nplate.
Among them, 33 people (0.19%) have Cataract.

Among these 33 people:
How long have people been on Nplate when they have Cataract? *
- < 1 month: 16.67 %
- 1 - 6 months: 50.0 %
- 6 - 12 months: 8.33 %
- 1 - 2 years: 8.33 %
- 2 - 5 years: 16.67 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
What is the gender of people who have Cataract when taking Nplate? *
- female: 56.67 %
- male: 43.33 %
What is the age of people who have Cataract when taking Nplate? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 15.79 %
- 60+: 84.21 %
What are other drugs people take besides Nplate? *
- Prednisone: 6 people, 18.18%
- Simvastatin: 6 people, 18.18%
- Dexamethasone: 5 people, 15.15%
- Vitamins: 5 people, 15.15%
- Lantus: 5 people, 15.15%
- Losartan Potassium: 4 people, 12.12%
- Cyclosporine: 4 people, 12.12%
- Rituxan: 3 people, 9.09%
- Prevpac: 2 people, 6.06%
- Ganciclovir: 2 people, 6.06%
What are other side effects people have besides Cataract? *
- Thrombocytopenia (decrease of platelets in blood): 20 people, 60.61%
- Drug Ineffective: 10 people, 30.30%
- Platelet Count Abnormal: 7 people, 21.21%
- Joint Pain: 7 people, 21.21%
- Blood Glucose Increased: 6 people, 18.18%
- Diarrhea: 6 people, 18.18%
- Thrombosis (formation of a blood clot inside a blood vessel): 6 people, 18.18%
- Dizziness: 5 people, 15.15%
- Headache (pain in head): 5 people, 15.15%
- Fatigue (feeling of tiredness): 5 people, 15.15%
What are the existing conditions these people have? *
- Idiopathic Thrombocytopenic Purpura (bleeding disorder in which the immune system destroys platelets, which are necessary for normal blood clotting): 15 people, 45.45%
- Thrombocytopenia (decrease of platelets in blood): 3 people, 9.09%
- Vulvovaginal Dryness: 1 person, 3.03%
- Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 1 person, 3.03%
- Constipation: 1 person, 3.03%
- Depression: 1 person, 3.03%
- Diabetes: 1 person, 3.03%
- Hepatitis (inflammation of the liver): 1 person, 3.03%
- Herpes Zoster: 1 person, 3.03%
- High Blood Pressure: 1 person, 3.03%
* Approximation only. Some reports may have incomplete information.
Do you take Nplate and have Cataract?
- Check whether Cataract is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Nplate:
- Nplate (17,850 reports)
Cataract treatments and more:
- Cataract (70,565 reports)
How severe was Cataract and when was it recovered:
Expand to all the drugs that have ingredients of romiplostim:
- Cataract and drugs with ingredients of romiplostim (28 reports)
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Nplate:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Cataract:
- Cataract (1,892 drugs)
Browse all the conditions that are associated with Cataract:
- Cataract (2,133 conditions)
Related publications that referenced our studies
- Lin SY, Lin CL, Ju SW, Wang IK, Lin CC, Lin CH, Hsu WH, Liang JA, "Increasing risk of cataract in HCV patients receiving anti-HCV therapy: A nationwide cohort study", PloS one, 2017 Mar .
- Dsouza MC, "Could risperidone have caused the cataract?: A case report and review of literature", Journal of Research in Psychiatry and Behavioral Science, 2015 Jan .
- Dsouza MC, "COULD RISPERIDONE HAVE CAUSED THE CATARACT", JRPBS, 2015 Jan .
- Lin SY, Lin CL, Ju SW, Wang IK, Lin CC, Lin CH, Hsu WH, Liang JA, "Increasing risk of cataract in HCV patients receiving anti-HCV therapy: A nationwide cohort study", PloS one, 2017 Mar .
- Dsouza MC, "Could risperidone have caused the cataract?: A case report and review of literature", Journal of Research in Psychiatry and Behavioral Science, 2015 Jan .
- Dsouza MC, "COULD RISPERIDONE HAVE CAUSED THE CATARACT", JRPBS, 2015 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on romiplostim (the active ingredients of Nplate) and Nplate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Topotecan and Mesna - 6 seconds ago
- Could Gilotrif cause Conjunctivitis? - 10 seconds ago
- Could Alendronate Sodium cause Cataract? - 15 seconds ago
- Could Lupron cause Biliary Dyskinesia? - 15 seconds ago
- Could Ifosfamide cause Abdominal Pain Upper? - 16 seconds ago
- Could Sandostatin Lar cause Vestibular Disorder? - 16 seconds ago
- Could Hc cause Crohn'S Disease Aggravated? - 16 seconds ago
- Could Famotidine cause Catheter Site Discharge? - 16 seconds ago
- Could Alendronate Sodium cause Polymyalgia Rheumatica Aggravated? - 17 seconds ago
- Could Tresiba cause Eye Pain? - 21 seconds ago